| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |